232 related articles for article (PubMed ID: 3352775)
21. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
22. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
23. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
24. [Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Peiffert D; Bey P; Lederlin P; Conroy T; Witz F
Bull Cancer; 1989; 76(4):373-82. PubMed ID: 2473814
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
[TBL] [Abstract][Full Text] [Related]
26. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P
Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
[TBL] [Abstract][Full Text] [Related]
27. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
28. [Hodgkin's disease in childhood: long term results].
Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
Arch Fr Pediatr; 1982 Apr; 39(4):223-9. PubMed ID: 6896975
[TBL] [Abstract][Full Text] [Related]
29. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
31. [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Glanzmann C; Stahel R
Praxis (Bern 1994); 1995 Oct; 84(41):1140-7. PubMed ID: 7481323
[TBL] [Abstract][Full Text] [Related]
32. Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
Mauch PM; Canellos GP; Rosenthal DS; Hellman S
J Clin Oncol; 1985 Apr; 3(4):501-5. PubMed ID: 3872348
[TBL] [Abstract][Full Text] [Related]
33. [Hodgkin's disease].
Ohtake S; Nakamura S
Rinsho Ketsueki; 1989 Aug; 30(8):1193-6. PubMed ID: 2601031
[TBL] [Abstract][Full Text] [Related]
34. Irradiation in the treatment of Hodgkin disease: a follow-up report.
Kim YH; Fayos JV
Radiology; 1981 May; 139(2):479-83. PubMed ID: 6894334
[TBL] [Abstract][Full Text] [Related]
35. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
[TBL] [Abstract][Full Text] [Related]
36. [Hodgkin's disease. Our 9-year experience with the 1980 protocol].
Marín J; Lasa R; Egurbide I; Etxebeste MA; Bengoetxea E; Angulo P; Antigüedad M; Furundarena JR; Peinado F; Navarro E
Sangre (Barc); 1992 Feb; 37(1):11-6. PubMed ID: 1585232
[TBL] [Abstract][Full Text] [Related]
37. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
[TBL] [Abstract][Full Text] [Related]
38. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
[TBL] [Abstract][Full Text] [Related]
39. Recent advances and controversies in the management of Hodgkin's disease.
O'Brien PH; Wallace K; Rambo VB
Surg Gynecol Obstet; 1975 Mar; 140(3):445-51. PubMed ID: 803722
[TBL] [Abstract][Full Text] [Related]
40. Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
Goodman R; Mauch P; Piro A; Rosenthal D; Goldstein M; Tullis J; Hellman S
Cancer; 1977 Jul; 40(1):84-9. PubMed ID: 406981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
